The Biomedical textiles market is deemed to grow from USD 10.74 billion in 2022 to USD 14.29 billion by 2028, with a CAGR of 5.2% during 2023-2028
The escalating number of surgeries, the rapid expansion of the aging population, the high quality of biomedical textiles, and the growing need for advanced wound dressing materials are the important factors predicted to drive the expansion of the biomedical textiles market during the foreseen period.
Every day, society changes in the form of a growing population and the desire for a longer lifespan. Factors like unavoidable situations and dangers arising in a civilization that brought an individual to a hospital and required aftercare are the reasons for the rising demand of the biomedical textiles market. Tissue engineering is an upcoming technology in which researchers are trying to develop tissues that allow the body to form new tissues around it. This would allow the body not to depend solely on the synthetic material implanted in the body. Medical textiles are a rapidly expanding segment of the biomedical textiles market that is predicted to experience strong expansion in the near future.
Expansion in the healthcare sector due to increased healthcare budget, growing healthcare awareness, and increased healthcare spending is likely to drive the biomedical textile market over the period. Furthermore, the escalating population size and the desire for a longer lifespan are predicted to stimulate the call for biomedical textiles in the healthcare industry to some extent. In addition, the increase in accident cases, lifestyle-related illnesses, and the frequent spread of infections are driving the need for technological innovations to facilitate the treatment process and are therefore predicted to provide a huge market for the biomedical textiles market in the health sector. In addition, a forthcoming technology, such as tissue engineering, in which specially designed tissue can form new tissue around it, allowing the body not to rely solely on synthetic material for the implant. The main factors driving the biomedical textiles market are the escalating number of surgeries and the escalating need for high-quality dressings that are driving the expansion of the market.
The huge capital required for R&D innovations and the production of biomedical textiles is likely to hold back the expansion of the worldwide biomedical textiles market during the foreseen period. The high cost of vascular grafts and artificial skin and the complexity of integrating electronic circuits into textiles for data processing are holding back market expansion.
The escalating geriatric population and escalating calls for wound care products such as casts, orthopedic implants, and gauze are predicted to accelerate the expansion of the biomedical textiles market during the foreseen period 2022 - 2027. On the other hand, an escalating call from emerging markets and the development of smart biomedical textiles are likely to drive the expansion of the biomedical textiles market during the foreseen period mentioned above.
High research and development costs are likely to hamper the expansion of the biomedical textiles market during the aforementioned foreseen period.
REPORT METRIC |
DETAILS |
Market Size Available |
2022-2028 |
Base Year |
2022 |
Forecast Period |
2023-2028 |
CAGR |
5.02% |
Segments Covered |
|
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
Regions Covered |
|
Market Leaders Profiled |
DSMMedtronic, Integra LifeScience, Freudenberg Group, Bally Ribbon Mills, ATEX TECHNOLOGIES, Confluent Medical Technologies, Elkem Silicones, BioSpace, KCWW., Mölnlycke Health Care AB, Rochal Industries LLC, AstraZeneca, 3M, Munksjö, Meister & Cie AG, Biomedical Structures LLC |
By Fiber type:
Non-biodegradable fibers are slowly absorbed by the body and take more than six months to break down. The non-biodegradable fiber type segment is predicted to record a higher CAGR than the biodegradable segment due to the high consumption of non-biodegradable fibers.
Woven
Non-woven
The nonwovens market is predicted to record the highest CAGR during the foreseen period. These fabrics offer superior performance properties such as excellent wicking softness, softness, strength, stretch, comfort, fit, and cost-effectiveness.
Non-implantable
implantable
The non-implantable applications segment is predicted to dominate the biomedical textiles market between 2021 and 2026.
The Biomedical Textiles Report includes the segmentation of Regions:
The Asia-Pacific region is predicted to be the fastest-growing market for biomedical textiles between 2021 and 2026. Emerging markets are predicted in the APAC region, such as China, India, and Singapore, with increased health spending and the increase in disposable income drive the expansion of the biomedical textiles market in the region. Furthermore, the escalating expenditure for the establishment of technical textile factories will directly stimulate the call for the biomedical textiles market. For example, the Gujarat (India) state government intends to establish a textile technical mission that would attract an investment of $ 1.62 billion for the establishment of 2,000 textile technical manufacturing facilities. Therefore, the expansion in the call for technical textiles will directly influence the call for biomedical textiles in the region. Asia-Pacific is predicted to be a very attractive market.
Rising number of healthcare centers to facilitate quality services is boosting up the demand of the market in Asia Pacific. The biomedical textiles market in the Middle East and Africa is likely to grow at a rapid pace. The North American and European markets are relatively mature and are predicted to experience consistent calls for biomedical textiles due to the limited scope of expansion during the foreseen period. The Middle East and Africa are predicted to see the growing call for biomedical textiles primarily from GCC countries due to their rapidly growing healthcare expansion plans to strengthen the industry over the period.
Medical device companies rely on healthcare facilities like pharmaceutical companies to collect clinical trial data. Most medical device products must undergo pre and post-marketing clinical trials before manufacturers can obtain marketing approval certificates. As the COVID-19 pandemic continues to unfold, medical device companies struggle to make informed decisions about their products, supply chains, and regulatory obligations amid uncertainty. Medical device professionals have the unenviable task of calling for a break in panic. No matter how serious or serious you are, here's the truth: Reckless action will make things worse. Despite the adrenaline rush that tells us to produce as quickly as possible, this is when quality matters more than anything else.
The major players covered in the biomedical textiles market report are
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2500
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]
Reports By Region